Neogenomics Inc (NEO)

May 16, 2025

NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference - ACCESS Newswire

May 16, 2025

May 15, 2025

NeoGenomics opposes US PTAB discretionary denial, citing public health concerns - MLex

May 15, 2025

May 15, 2025

Guggenheim Begins Coverage of NeoGenomics (NEO) with Neutral Stance | NEO Stock News - GuruFocus

May 15, 2025

May 15, 2025

Guggenheim Initiates Coverage on NeoGenomics With Neutral Rating - marketscreener.com

May 15, 2025

May 15, 2025

NeoGenomics (NEO) Initiated with Neutral Rating by Guggenheim Analyst | NEO Stock News - GuruFocus

May 15, 2025

May 13, 2025

NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook - Yahoo Finance

May 13, 2025

May 10, 2025

Insider Buying: Stephen Kanovsky Acquires Shares of NeoGenomics Inc (NEO) - GuruFocus

May 10, 2025

May 09, 2025

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares - Yahoo Finance

May 09, 2025

May 09, 2025

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in oncology using the UG 100 sequencing platform - SelectScience

May 09, 2025

May 07, 2025

Insider Buying: Neil Gunn Acquires Shares of NeoGenomics Inc (NE - GuruFocus

May 07, 2025

May 06, 2025

Assessing NeoGenomics: Insights From 9 Financial Analysts - Benzinga

May 06, 2025

May 06, 2025

Piper Sandler Lowers Price Target on NeoGenomics (NEO) to $12.00 - GuruFocus

May 06, 2025

May 06, 2025

Piper Sandler Lowers Price Target on NeoGenomics (NEO) to $12.00 | NEO Stock News - GuruFocus

May 06, 2025

May 06, 2025

It's Not Too Late to Jump on These Under-the-Radar Momentum Plays - Investing.com

May 06, 2025

May 06, 2025

It's Not Too Late to Jump on These Under-the-Radar Momentum Plays - MarketBeat

May 06, 2025

May 06, 2025

NeoGenomics (NEO) Receives Adjusted Price Target from Piper Sand - GuruFocus

May 06, 2025

May 06, 2025

NeoGenomics (NEO) Receives Adjusted Price Target from Piper Sandler | NEO Stock News - GuruFocus

May 06, 2025

May 05, 2025

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo

May 05, 2025

May 03, 2025

How to Take Advantage of moves in (NEO) - news.stocktradersdaily.com

May 03, 2025

May 02, 2025

NeoGenomics, Inc. to Host Earnings Call - ACCESS Newswire

May 02, 2025

May 01, 2025

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2025 Earnings Call Transcript - MSN

May 01, 2025

May 01, 2025

NeoGenomics (NEO) Price Target Lowered by Morgan Stanley | NEO S - GuruFocus

May 01, 2025

May 01, 2025

NeoGenomics (NEO) Price Target Lowered by Morgan Stanley | NEO Stock News - GuruFocus

May 01, 2025

May 01, 2025

NeoGenomics Repays $201.3 Million Convertible Senior Notes - marketscreener.com

May 01, 2025

May 01, 2025

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley - Yahoo Finance

May 01, 2025

May 01, 2025

NeoGenomics clears $201.25M convertible debt ahead of maturity By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

NeoGenomics clears $201.25M convertible debt ahead of maturity - Investing.com

May 01, 2025

May 01, 2025

NeoGenomics Pays Off 1.25% Convertible Senior Notes - Yahoo Finance

May 01, 2025

May 01, 2025

NeoGenomics (NEO) Shares Drop After Disappointing Q1 Revenue Rep - GuruFocus

May 01, 2025

May 01, 2025

NeoGenomics targets 25% annual NGS growth with new product launches in 2025 - MSN

May 01, 2025

Apr 30, 2025

NeoGenomics (NEO) Stock Target Reduced by Morgan Stanley Amid Q1 - GuruFocus

Apr 30, 2025

Apr 30, 2025

Leerink Partners Downgrades NeoGenomics (BMV:NEO) - Nasdaq

Apr 30, 2025

Apr 30, 2025

Health Care Stocks Rise As Pfizer And AstraZeneca Lead Gains - Finimize

Apr 30, 2025

Apr 30, 2025

NeoGenomics (NEO) Faces Price Target Cut Amid Significant Selloff | NEO Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

NeoGenomics (NEO) Faces Price Target Reduction Amid Sales Challe - GuruFocus

Apr 30, 2025

Apr 30, 2025

NeoGenomics (NEO) Price Target Cut by BTIG Amid Revenue Concerns - GuruFocus

Apr 30, 2025

Apr 30, 2025

NeoGenomics stock hits 52-week low at $6.25 amid market challenges - Investing.com India

Apr 30, 2025

Apr 30, 2025

NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade) (NEO) - Seeking Alpha

Apr 30, 2025

Apr 30, 2025

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Apr 30, 2025

Apr 30, 2025

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform - BioSpace

Apr 30, 2025

Apr 30, 2025

Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga

Apr 30, 2025

Apr 30, 2025

NeoGenomics Reports Strong Q1 2025 Performance - TipRanks

Apr 30, 2025

Apr 30, 2025

NeoGenomics (NEO) Kicks Off 2025 with Strong Revenue Momentum | - GuruFocus

Apr 30, 2025

Apr 29, 2025

NeoGenomics: Q1 Earnings Snapshot - MySA

Apr 29, 2025

Apr 29, 2025

NeoGenomics Reports Strong Q1 2025 Earnings Growth - TipRanks

Apr 29, 2025

Apr 29, 2025

NeoGenomics Q1 2025 Earnings Call Transcript - MarketBeat

Apr 29, 2025

Apr 29, 2025

NeoGenomics (NEO) Downgraded Amid Growth Concerns | NEO Stock Ne - GuruFocus

Apr 29, 2025

Apr 29, 2025

Why NeoGenomics (NEO) Stock Is Nosediving - MSN

Apr 29, 2025

Apr 29, 2025

Fort Myers-based NeoGenomics posts $26M net loss in Q1 - Gulfshore Business

Apr 29, 2025

Apr 29, 2025

Earnings call transcript: NeoGenomics Q1 2025 revenue misses forecast, stock drops - Investing.com Nigeria

Apr 29, 2025

Apr 29, 2025

NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN

Apr 29, 2025

Apr 29, 2025

NeoGenomics stock drops on Q1 miss (NEO:NASDAQ) - Seeking Alpha

Apr 29, 2025

Apr 29, 2025

NeoGenomics Q1 2025 Financial Results: Sales Growth Amid Profitability ChallengesNews and Statistics - IndexBox

Apr 29, 2025

Apr 29, 2025

NeoGenomics Reports First Quarter 2025 Results - BioSpace

Apr 29, 2025

Apr 29, 2025

NeoGenomics and Ultima Genomics collaborate to expand clinical t - GuruFocus

Apr 29, 2025